Ramipril v placebo for adults at high risk for cardiovascular (CV) events‡

Outcomes at mean 4 yRamiprilPlaceboRRR (95% CI)NNT (CI)
‡CV = cardiovascular; MI = myocardial infarction. Other abbreviations defined in glossary; RRR, NNT, and CI provided by authors.
MI, stroke, or CV mortality14%18%22% (14 to 30)26 (19 to 43)
CV mortality 6% 8%26% (13 to 36)50 (33 to 105)
MI10%12%20% (10 to 30)42 (27 to 89)
Stroke 3% 5%32% (16 to 44)67 (43 to 145)
All cause mortality10%12%16% (5 to 25)56 (32 to 195)